Recruiting Advanced Solid Tumors Studies in Kashiwa
S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Advanced or Metastatic Solid Tumors
The primary objective of Part A is to evaluate the safety and tolerability of S-531011 and to determine the maximum tolerated dose (MTD) and/or recommended Phase 2 dose (RP2D) of S-531011. The primar...
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors...
About Advanced Solid Tumors Clinical Trials in Kashiwa
Advanced solid tumors refer to cancers that have grown beyond the original site or spread to distant organs. Many clinical trials enroll patients with various types of advanced solid tumors to test novel therapies. These trials often investigate immunotherapy, targeted therapy, and combination approaches.
There are currently 2 advanced solid tumors clinical trials recruiting participants in Kashiwa, CHIBA. These studies are seeking a combined 334 participants. Research is being sponsored by Shionogi, AstraZeneca. Clinical trial participation is free and participants receive study-related medical care at no cost.
Advanced Solid Tumors Clinical Trials in Kashiwa — FAQ
Are there advanced solid tumors clinical trials in Kashiwa?
Yes, there are 2 advanced solid tumors clinical trials currently recruiting in Kashiwa, CHIBA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Kashiwa?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Kashiwa research site will contact you about next steps.
Are clinical trials in Kashiwa free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Kashiwa studies also compensate for your time and travel.
What advanced solid tumors treatments are being tested?
The 2 active trials in Kashiwa are testing new therapies including novel drugs, biologics, and treatment approaches for advanced solid tumors.
Data updated March 2, 2026 from ClinicalTrials.gov